EP3875085
EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.11.2019EP published:
19.6.2024EP application number:
19880770.3
EPO information:
European Patent Register
Max expiry date:
31.10.2039
Title in English:
EDARAVONE SUSPENSION FOR ORAL ADMINISTRATIONLanguage of the patent:
English
Timeline
Today
1.11.2019EP application
19.6.2024EP Publication
Owner
Name:
Mitsubishi Tanabe Pharma CorporationAddress:
3-2-10, Dosho-machi, Chuo-ku,, Osaka-shi, Osaka 541-8505, JP
Inventor
Name:
HAYAMA, TetsuoAddress:
Osaka-shi, Osaka 541-8505, JP
Name:
TAKAHASHI, TomohiroAddress:
Osaka-shi, Osaka 541-8505, JP
Name:
OMURA, TomoyukiAddress:
Osaka-shi, Osaka 541-8505, JP
Name:
HAYASHI, KoujiAddress:
Osaka-shi, Osaka 541-8505, JP
Name:
MATSUDA, MunetomoAddress:
Osaka-shi, Osaka 541-8505, JP
Name:
MIYAZAWA, TadashiAddress:
Osaka-shi, Osaka 541-8505, JP
Priority
Number:
2018207646Date:
2.11.2018Country:
JP
Classification
Categories:
A61K 9/10, A61K 31/4152, A61K 47/32, A61K 47/36, A61K 47/38, A61P 21/02, A61P 25/28